Detalles de la búsqueda
1.
Pembrolizumab plus chemotherapy versus chemotherapy in untreated advanced pleural mesothelioma in Canada, Italy, and France: a phase 3, open-label, randomised controlled trial.
Lancet
; 402(10419): 2295-2306, 2023 12 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-37931632
2.
A population-based analysis of spirometry use and the prevalence of chronic obstructive pulmonary disease in lung cancer.
BMC Cancer
; 21(1): 14, 2021 Jan 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33402114
3.
Trial marketing in the Pan-Canadian Early Detection of Lung Cancer Study.
Clin Trials
; 17(2): 202-211, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31894702
4.
Chronic obstructive pulmonary disease prevalence and prediction in a high-risk lung cancer screening population.
BMC Pulm Med
; 20(1): 300, 2020 Nov 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-33198781
5.
Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study.
Lancet Oncol
; 18(11): 1523-1531, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29055736
6.
Performance of the cancer risk management model lung cancer screening module.
Health Rep
; 26(5): 11-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25993046
7.
Optimizing the number of variants tracked to follow disease burden with circulating tumor DNA assays in metastatic colorectal cancer.
Ther Adv Med Oncol
; 15: 17588359231183682, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37389190
8.
Liver Metastases and Immune Checkpoint Inhibitor Efficacy in Patients With Refractory Metastatic Colorectal Cancer: A Secondary Analysis of a Randomized Clinical Trial.
JAMA Netw Open
; 6(12): e2346094, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38051531
9.
Brief Report: Canadian Cancer Trials Group IND.227: A Phase 2 Randomized Study of Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma (NCT02784171).
J Thorac Oncol
; 18(6): 813-819, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36841541
10.
A phase II study of the halichondrin B analog eribulin mesylate in gemcitabine refractory advanced pancreatic cancer.
Invest New Drugs
; 30(3): 1203-7, 2012 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21526355
11.
Do beta-blockers alter dyspnea and fatigue in advanced lung cancer? A retrospective analysis.
Palliat Med
; 26(6): 797-803, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-21844136
12.
A comparison of a new multinomial stopping rule with stopping rules of fleming and gehan in single arm phase II cancer clinical trials.
BMC Med Res Methodol
; 11: 95, 2011 Jun 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-21693051
13.
Stopping rules employing response rates, time to progression, and early progressive disease for phase II oncology trials.
BMC Med Res Methodol
; 11: 164, 2011 Dec 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-22151297
14.
Management and outcomes of patients with chronic obstructive lung disease and lung cancer in a public healthcare system.
PLoS One
; 16(5): e0251886, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33999942
15.
Risk Perception Among a Lung Cancer Screening Population.
Chest
; 160(2): 718-730, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33667493
16.
Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
CMAJ Open
; 8(3): E585-E592, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32963023
17.
Effect of Combined Immune Checkpoint Inhibition vs Best Supportive Care Alone in Patients With Advanced Colorectal Cancer: The Canadian Cancer Trials Group CO.26 Study.
JAMA Oncol
; 6(6): 831-838, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32379280
18.
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth.
Front Oncol
; 10: 575148, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33330049
19.
Selumetinib in patients receiving standard pemetrexed and platinum-based chemotherapy for advanced or metastatic KRAS wildtype or unknown non-squamous non-small cell lung cancer: A randomized, multicenter, phase II study. Canadian Cancer Trials Group (CCTG) IND.219.
Lung Cancer
; 133: 48-55, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31200828
20.
A Randomized Phase II Study of FOLFOX6/Bevacizumab With or Without Pelareorep in Patients With Metastatic Colorectal Cancer: IND.210, a Canadian Cancer Trials Group Trial.
Clin Colorectal Cancer
; 17(3): 231-239.e7, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29653857